Eversept Partners’s Incyte INCY Stock Holding History

Eversept Partners’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-63,996	Closed	-$5.14M	–	72
2022 Q4	$5.14M	Buy	+63,996	New	+$4.9M	0.45%	40

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Eversept Partners's INCY Position: Q1 2023 in Review

Eversept Partners sold out of Incyte (INCY) in Q1 2023, closing a stake of 63,996 shares — an estimated $5.14M sold.

Eversept Partners first reported a position in INCY in Q4 2022 and held it in 1 quarter. The position peaked at $5.14M in Q4 2022. 550 funds tracked by Wall St. Rank hold INCY as of Q1 2023.

Eversept Partners reported no remaining Incyte position as of Q1 2023 after selling out during the quarter.
Eversept Partners sold 63,996 Incyte shares in Q1 2023, an estimated $5.14M.
Eversept Partners first reported a position in Incyte in Q4 2022 and held it in 1 quarter.
Eversept Partners's Incyte position peaked at $5.14M in Q4 2022.
550 funds tracked by Wall St. Rank held Incyte as of Q1 2023.

Based on Eversept Partners's 13F filing for Q1 2023, filed 15 May 2023.